Literature DB >> 2476700

Growth features of choroidal neovascular membranes in age-related macular degeneration.

M L Klein1, P A Jorizzo, R C Watzke.   

Abstract

The authors studied 80 eyes of patients with choroidal neovascular membranes (CNVMs) associated with age-related macular degeneration between 1982 and 1988. In each case, fluorescein angiography was done on two occasions separated by an interval of 2 days to 11 weeks (average, 13 days) without intervening photocoagulation. Forty-three CNVMs (54%) grew toward the fovea during the interval between fluorescein angiograms, with growth rates ranging from 1 to 24 microns daily (average, 10 microns daily). The CNVM growth was related to the time interval between angiograms (P less than 0.0001), but was not associated with morphologic features of the CNVM. These results reinforce the need for early detection and prompt evaluation of elderly patients with symptoms of CNVMs.

Entities:  

Mesh:

Year:  1989        PMID: 2476700     DOI: 10.1016/s0161-6420(89)32741-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  Symmetry of disciform scars in bilateral age-related macular degeneration.

Authors:  M J Lavin; B Eldem; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

2.  Scanning laser fundus perimetry before laser photocoagulation of well defined choroidal neovascularisation.

Authors:  K Rohrschneider; R Glück; M Becker; F G Holz; F E Kruse; T Fendrich; H E Völcker
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

3.  Relation between macular morphology and visual function in patients with choroidal neovascularisation of age related macular degeneration.

Authors:  N Doris; P M Hart; U Chakravarthy; J McCleland; M Stevenson; C Hudson; J Jackson
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

Review 4.  25th RCOphth Congress, President's Session paper: 25 years of progress in medical retina.

Authors:  J M Gibson
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

5.  Transcriptomic analysis across nasal, temporal, and macular regions of human neural retina and RPE/choroid by RNA-Seq.

Authors:  S Scott Whitmore; Alex H Wagner; Adam P DeLuca; Arlene V Drack; Edwin M Stone; Budd A Tucker; Shemin Zeng; Terry A Braun; Robert F Mullins; Todd E Scheetz
Journal:  Exp Eye Res       Date:  2014-11-05       Impact factor: 3.467

Review 6.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  The significance of early treatment of exudative age-related macular degeneration: 12 months' results.

Authors:  Birgit Weingessel; Gregor Hintermayer; Saskia M Maca; Renate Rauch; Pia Veronika Vecsei-Marlovits
Journal:  Wien Klin Wochenschr       Date:  2012-10-24       Impact factor: 1.704

8.  Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study.

Authors:  G J Bergink; A F Deutman; J F van den Broek; W A van Daal; R W van der Maazen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

9.  Assessment of visual distortions in age-related macular degeneration: emergence of new approaches.

Authors:  Noelia Pitrelli Vazquez; Paul C Knox
Journal:  Br Ir Orthopt J       Date:  2015

10.  Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration.

Authors:  Youxin Chen; Fei Han
Journal:  Ther Clin Risk Manag       Date:  2012-07-11       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.